While the cannabis industry focuses on the DEA and DOJ regarding potential federal rescheduling or legalization, other regulatory bodies pose significant operational risks. Once federal barriers fall, agencies like the FDA, TTB, and OSHA will likely exert authority over the sector. The FDA will almost certainly mandate strict standards for product safety, labeling, and health claims—a shift that will force many current operators to overhaul their existing production processes.
Similarly, the TTB—which governs alcohol and tobacco—could oversee taxation and interstate commerce, potentially imposing rigid excise structures that mirror those found in the alcohol industry. Businesses that ignore these agencies risk severe non-compliance penalties. Furthermore, the FTC will monitor marketing practices to ensure advertising does not target minors or make unsubstantiated medical claims.
Preparation requires a transition from state-level compliance to a federal mindset. Owners must audit their current supply chains, quality control protocols, and marketing materials now. Waiting for formal legislation to pass will leave firms vulnerable to sudden enforcement actions.
The transition will favor companies that prioritize transparency and rigorous documentation over those relying on the current fragmented regulatory environment.